Abstract:In calcium nephrolithiasis (CaNL), most calcium kidney stones are identified as calcium oxalate (CaOx) with variable amounts of calcium phosphate (CaP), where CaP is found as the core component. The nucleation of CaP could be the first step of CaP+CaOx (mixed) stone formation. High urinary supersaturation of CaP due to hypercalciuria and an elevated urine pH have been described as the two main factors in the nucleation of CaP crystals. Our previous in vivo findings (in mice) show that transient receptor potential canonical type 3 (TRPC3)-mediated Ca2+ entry triggers a transepithelial Ca2+ flux to regulate proximal tubular (PT) luminal [Ca2+], and TRPC3-knockout (KO; -/-) mice exhibited moderate hypercalciuria and microcrystal formation at the loop of Henle (LOH). Therefore, we utilized TRPC3 KO mice and exposed them to both hypercalciuric [2% calcium gluconate (CaG) treatment] and alkalineuric conditions [0.08% acetazolamide (ACZ) treatment] to generate a CaNL phenotype. Our results revealed a significant CaP and mixed crystal formation in those treated KO mice (KOT) compared to their WT counterparts (WTT). Importantly, prolonged exposure to CaG and ACZ resulted in a further increase in crystal size for both treated groups (WTT and KOT), but the KOT mice crystal sizes were markedly larger. Moreover, kidney tissue sections of the KOT mice displayed a greater CaP and mixed microcrystal formation than the kidney sections of the WTT group, specifically in the outer and inner medullary and calyceal region; thus, a higher degree of calcifications and mixed calcium lithiasis in the kidneys of the KOT group was displayed. In our effort to find the Ca2+ signaling pathophysiology of PT cells, we found that PT cells from both treated groups (WTT and KOT) elicited a larger Ca2+ entry compared to the WT counterparts because of significant inhibition by the store-operated Ca2+ entry (SOCE) inhibitor, Pyr6. In the presence of both SOCE (Pyr6) and ROCE (receptor-operated Ca2+ entry) inhibitors (Pyr10), Ca2+ entry by WTT cells was moderately inhibited, suggesting that the Ca2+ and pH levels exerted sensitivity changes in response to ROCE and SOCE. An assessment of the gene expression profiles in the PT cells of WTT and KOT mice revealed a safeguarding effect of TRPC3 against detrimental processes (calcification, fibrosis, inflammation, and apoptosis) in the presence of higher pH and hypercalciuric conditions in mice. Together, these findings show that compromise in both the ROCE and SOCE mechanisms in the absence of TRPC3 under hypercalciuric plus higher tubular pH conditions results in higher CaP and mixed crystal formation and that TRPC3 is protective against those adverse effects.

Paracellular Transport and Renal Tubule Calcium Handling: Emerging Roles in Kidney Stone Disease

Biology of calcium homeostasis regulation in intestine and kidney

An overview of divalent cation and citrate handling by the kidney

Hypertension and renal calcium transport

Calcium transport in the kidney

The importance of kidney calcium handling in the homeostasis of extracellular fluid calcium

Calcium-permeable Ion Channels in the Kidney

Effects of parathyroid hormone on renal tubular calcium and phosphate handling

Novel Insights into Renal Mineralization and Stone Formation Through Advanced Imaging Modalities

Intracellular Calcium Homeostasis and Kidney Disease.

Understanding formation processes of calcareous nephrolithiasis in renal interstitium and tubule lumen

TRPV5 in renal tubular calcium handling and its potential relevance for nephrolithiasis

Activation of the Ca(2+)-sensing receptor increases renal claudin-14 expression and urinary Ca(2+) excretion

The Rise in Tubular pH during Hypercalciuria Exacerbates Calcium Stone Formation

Regulation of calcium reabsorption along the rat nephron: a modeling study

Progress in Understanding the Genetics of Calcium-Containing Nephrolithiasis

Recent advances on the mechanisms of kidney stone formation (Review)

SLC26A6 and NADC-1: Future direction of nephrolithiasis and calculus-related hypertension research

The Role of Calcium in the Prevention of Kidney Stones

Genetics of kidney stone disease-Polygenic meets monogenic

Immunotherapy for stone disease